Zusammenfassung
Der Spontanabort ist die häufigste Komplikation der Frühschwangerschaft. Er wird meist durch zytogenetische Anomalien verursacht. Das Risiko eines Spontanaborts ist vor allem vom mütterlichen Alter abhängig. Idiopathische rezidivierende Spontanaborte (iRSA) werden diagnostiziert, wenn die Ursachen für rezidivierende Spontanaborte (RSA) unbekannt sind. Es kann derzeit keine Empfehlung für eine Standardtherapie bei iRSA ausgesprochen werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
American College of Obstetricians and Gynecologists (2002) ACOG Practice Bulletin. Management of recurrent pregnancy loss. Int J Gynaecol Obstet 78(2): 179–190
American Society for Reproductive Medicine (ASRM) Practice Committee of the American Society for Reproductive Medicine (2012) Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 98(5): 1103–1111
Andersen AN, Wohlfahrt J, Christens P, Olsen J, Melbye M (2000) Maternal age and fetal loss: population based register linkage study. Brit Med J 320: 1708–1712
Barnhart KT, Sammel M, Rinaudo PF, Zhou L, Hummel AC, Guo W (2004) Symptomatic patients with an early viable intrauterine pregnancy – hCG curves redefined. Obstet Gynecol 104: 50–55
Boklage CE (1990) Survival probability of human conceptions from fertilization to term. Int J Fertil 35: 75–94
Carmichael SL (2013) Hypospadias and maternal intake of phytoestrogens. Am J Epidemiol 178(3): 434–440
Carrington B, Sacks G, Regan L (2005) Recurrent miscarriage: pathophysiology and outcome. Curr Opin Obstet Gynecol 17(6): 591–597
Check JH (2012) The use of heparin for preventing miscarriage. Am J Reprod Immunol 67(4): 326–333
Clifford K, Rai R, Regan L (1997) Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Human Reproduction 12(2): 387–389
Coomarasamy A, Truchanowicz EG, Rai R (2011) Does first trimester progesterone prophylaxis increase the live birth rate in women with unexplained recurrent miscarriages? BMJ 342: 1914
Coomarasamy A, Williams H, Truchanowicz E, Seed PT, Small R, Quenby S, Gupta P, Dawood F, Koot YE, Bender Atik R, Bloemenkamp KW, Brady R, Briley AL, Cavallaro R, Cheong YC, Chu JJ, Eapen A, Ewies A, Hoek A, Kaaijk EM, Koks CA, Li TC, MacLean M, Mol BW, Moore J, Ross JA, Sharpe L, Stewart J, Vaithilingam N, Farquharson RG, Kilby MD, Khalaf Y, Goddijn M, Regan L, Rai R (2015) A randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med 373(22): 2141–2148
Fawzy M (2008) Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. Arch Gynecol Obstet 278(1): 33–38
Field K, Murphy DJ (2015) Perinatal outcomes in a subsequent pregnancy among women who have experienced recurrent miscarriage: a retrospective cohort study. Hum Reprod 30: 1239
Gerhard I, Daniel F, Runnebaum B (1996) Habitueller Abort. Gynäkol Prax 20: 13–24
Goetzl L, Krantz D, Simpson JL, Silver RK, Zachary JM (2004) Pregnancy-associated plasma protein A, free ß-hCG, nuchal translucency, and risk of pregnancy loss. Obstetrics Gynecol 104: 30–36
Gris JC (2011) LMWH have no place in recurrent pregnancy loss: debate-against the motion. Thromb Res 127 (suppl 3): S110–112
Harger JH, Archer DF, Marchese SG (1983) Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet Gynecol 62: 574
Hsu, LYF (1998) Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Milunsky A (ed) Genetic disorders and the fetus. Johns Hopkins University Press, Baltimore, p. 179
Jauniaux E (2006) Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 21(9): 2216–2222
Jeng GT, Scott JR, Burmeister LF (1995) A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage.JAMA 274(10): 830–836
Jivraj S, Anstie B, Cheong YC (2001) Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study. Hum Reprod 16: 102
de Jong PG, Goddijn M, Middeldorp S (2013) Antithrombotic therapy for pregnancy loss. Hum Reprod Update 19(6): 656–673
Kaandorp S (2009) Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst Rev 1: CD004734
Kaandorp S (2010) Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 362(17): 1586–1589
Liddell HS, Pattison NS, and Zanderigo A (1991) Recurrent miscarriage - outcome after supportive care in early pregnancy. Aust N Z J Obstet Gynaecol 31(4): 320–322
McCracken SA (1999) Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta. Biol Reprod 60(4): 790–796
Musters AM (2013) Supportive care for women with recurrent miscarriage: a survey to quantify women′s preferences. Hum Reprod 28(2): 398–405
Nybo Andersen AM, Wohlfahrt J, Christens P (2000) Maternal age and fetal loss: population based register linkage study. BMJ 320: 1708
Ogasawara M, Aoki K, Okada S, Suzumori K (2000) Embryonic karyotype of abortuses in relation to the number of previous miscarriages.Fertil Steril 73(2): 300–304
Osborn JF, Cattaruzza MS, Spinelli A (2000) Risk of spontaneous abortion in Italy, 1978-1995, and the effect of maternal age, gravidity, marital status, and education. Am J Epidemiol 151: 98
Philipp T, Philipp K, Reiner A, Beer F, Kalousek DK (2003) Embryoscopic and cytogenetic analysis of 233 missed abortions: factors involved in the pathogenesis of developmental defects of early failed pregnancies. Hum Reprod 18(8): 1724–1732
Regan L, Rai R (2000) Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 14: 839
Royal College of Obstetricians and Gynaecologists (RCOG) (2011) Recurrent Miscarriage, Investigation and Treatment of Couples (Green-top Guideline No. 17). https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg17 (Zugriff: 30.08.2015)
Santjohanser C (2013) Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage. Arch Immunol Ther Exp 61(2): 159–164
Saravelos SH, Li TC (2012) Unexplained recurrent miscarriage: how can we explain it? Human Reproduction 27(7): 1882–1886
Scarpellini F, Sbracia M (2009) Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod 24(11): 2703–2708
Scott JR (1994) Recurrent miscarriage: overview and recommendations. Clin Obstet Gynecol 37: 768
Scott JR, Pattison N (2000) Human chorionic gonadotrophin for recurrent miscarriage. Cochrane Database Syst Rev 2: CD000101
Schleussner E, Kamin G, Seliger G, Rogenhofer N, Ebner S, Toth B, Schenk M, Henes M, Bohlmann MK, Fischer T, Brosteanu O, Bauersachs R, Petroff D; ETHIG II group (2015) Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme. Ann Intern Med 162(9): 601–609
Stray-Pedersen B, Stray-Pedersen S (1984) Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 148(2): 140–146
Stray-Pedersen B, Stray-Pedersen S (1988) Recurrent abortion: The role of psychotherapy. In: Beard R, Sharp F (eds.) Early pregnancy loss. Mechanisms and treatment. Springer, Heidelberg, p. 433–440
Tempfer CB, Kurz C, Bentz EK, Unfried G, Walch K, Czizek U, Huber JC (2006) A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study. Fertil Steril 86(1): 145–148
Toth B et al.; Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) und Arbeitsgemeinschaft Immunologie in der Gynäkologie und Geburtshilfe (AGIM) (2014) Diagnostik und Therapie beim wiederholten Spontanabort. AWMF-Leitlinie 015/050. http://www.awmf.org/uploads/tx_szleitlinien/015-050k_S1_Spontanabort_Diagnostik_Therapie_2014-05.pdf (Zugriff: 30.08.2015)
Wallace EM, Marjono B, Tyzack K, Tong S (2004) First trimester levels of inhibins and activin A in normal and failing pregnancies. Clin Endocrinol 60: 484–490
Wang X, Chen C, Wang L (2003) Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril 79: 577
Wilcox AJ, Weinberg CR, O´Connor JF, Baird DD, Schlatterer JP (1988) Incidence of early loss of prgnancy. N Engl J Med 319: 189–194
World Health Organization (WHO) (1977) Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand 56(3): 247–253
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tempfer, C. (2017). Idiopathische rezidivierende Aborte. In: Toth, B. (eds) Fehlgeburten Totgeburten Frühgeburten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50424-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-662-50424-6_19
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-50423-9
Online ISBN: 978-3-662-50424-6
eBook Packages: Medicine (German Language)